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ABSTRACT. The main purpose of this multicenter ex post facto prospective study
is to examine the psychometric properties of the Addiction Severity Index version 6.0
(ASI-6) in Spanish outpatients and determine the predictor variables of treatment
adherence. A total of 186 outpatients with a substance dependence diagnosis (mean age
40 years; 80% male) were assessed with the ASI-6 and Clinical Global Impression
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(CGI). Results revealed a moderate decrease in ASI-6 recent summary scores (RSSs)
in the Alcohol (t = 4.77; p < .001), Drug (t = 2.01; p = .035), Psychiatric Status
(t = 5.47; p < .001) and Family/Social Relationships areas (t = 3.55; p < .001) from
baseline to six months. The adjusted odds ratio (OR) related to an increased probability
of adherence was 1.23 for the CGI-S score (95% CI 1.10-1.38). On the contrary, lower
adherence was predicted by Severity in the Drug Scale with an OR of .95 (95% CI
.92-.98). The Spanish ASI-6 appears to be a valid instrument that is sensitive to
therapeutic change, providing relevant and reliable information not only about severity
of addiction but also about substance abuse treatment adherence prediction.
KEYWORDS. Addiction Severity Index. Sensitivity to change. Retention. Prospective
ex post facto study.
RESUMEN. El principal objetivo de este estudio multicéntrico expostfacto, prospectivo
de seis meses de duración, fue analizar las propiedades psicométricas de la sexta versión
del Índice de Severidad de la Adicción (ASI-6) en pacientes ambulatorios españoles y
determinar variables predictoras de la adherencia al tratamiento. Contamos con 186
pacientes ambulatorios con diagnóstico de dependencia de sustancias, con edad media
de 40 años, 80% varones, evaluados mediante el ASI-6 e Impresión Clínica Global. Se
observa una disminución moderada de las Puntuaciones Observadas Estandarizadas –
POEs- en el área Alcohol (t = 4.77, p < .001), Drogas (t = 2.01, p = .035), Estado
Psiquiátrico (t = 5.47; p < .001) y área Familiar (t = 3.55, p < .001) en los seis meses
de tratamiento. La impresión clínica de gravedad es la variable que mejor predice la
adherencia al tratamiento [OR=1.23 (IC del 95%, 1.10 – 1.38)]. Por el contrario, el
riesgo de abandono fue predicho por la mayor gravedad en la POE del área Drogas
[OR=.95 (IC 95%, .92 - .98)]. La versión española del ASI-6 puede ser un instrumento
válido y sensible al cambio terapéutico, que proporciona información relevante tanto
sobre la gravedad como sobre la predicción de la adherencia al tratamiento.
PALABRAS CLAVE. Índice de gravedad de la adicción. Sensibilidad al cambio. Reten-
ción. Estudio prospectivo ex post facto.
Clinical instruments should possess accurate and refined psychometric properties
in order to evaluate and estimate the efficacy of interventions. Therefore, it is of great
importance for an assessment questionnaire to prove both fair sensitivity to change and
predictive power of treatment adherence in order to monitor patient progress and yield
an optimum intervention algorithm for each client. This need to «assess the effectiveness
and generate new evidence» was recently promoted at the World Health Organization
Helsinki Ministerial Conference on Mental Health (World Health Organization, 2005).
Since 1979, the Addiction Severity Index –ASI- (McLellan, Alterman, Cacciola,
Metzger, and O’Brien, 1992; McLellan, Luborsky, Woody, and O’Brien, 1980) has become
one of the most relevant instruments for substance use disorders in both clinical and
research settings; in all its versions and in different contexts: prisons, outpatient,
residential or substitutive methadone therapy (Alterman, Cacciola, Dugosh, Ivey, and
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Coviello, 2010; Cacciola, Alterman, McLellan, Lin, and Lynch, 2007; Cacciola, Dugosh,
and Camilleri, 2009; Casares-López et al., 2010; McLellan, Cacciola, Alterman, Rikoon,
and Carise, 2006). This structured interview was designed to provide basic information
on various areas of patients’ lives and to monitor clinical changes and treatment
outcomes. Specifically, ASI-6 focuses on patient functioning in seven problem areas
commonly involved in substance use disorders (SUDs), including medical status,
employment, drug and alcohol use, illegal activity, family/social relationships (problems
with children, family/social support and problems), and psychiatric status. The sixth
version of the ASI was recently adapted into Spanish, and although it has demonstrated
acceptable psychometric properties for use in clinical practice and it has sensitivity to
change over time, in other words, the degree to which it reflects client variations that
occur due to therapy has yet to be explored (Díaz-Mesa et al., 2010). Concomitantly,
duration of treatment adherence is one of the most important predictors of successful
outcomes in rehabilitation programs (Hill and Lambert, 2004). However, dropout rates are
exponential, ranging between 60 and 80% of patients in residential and outpatient
settings (Guy, 1976; Hill and Lambert, 2004). The literature on this issue is still equivocal,
as a wide variety of potential predictors have been proposed including demographics,
dual diagnosis, personality disorders, treatment history, antisocial behaviors, and drug
use severity. The ASI-6 provides relevant information about a number of individual
variables that may have a role in adherence (i.e., age of first use and onset of abuse,
existence of trauma and sequelae).
Within this research context, the main objectives of this quasi experimental study,
subtype pretest-posttest and with one group (Carretero-Dios and Pérez, 2007; Montero
and León, 2007; Ramos-Álvarez, Moreno-Fernández, Valdés-Conroy, and Catena, 2008)
are: a) to characterize the addiction severity pattern over 6 months of standard outpatient
treatment; b) to explore potential baseline differences by adherence, and finally; c) to
identify patient characteristics that may predict retention.
Method
This is a naturalistic, multicentre, 6-month follow-up study conducted in Spain. It
was approved by the Ethics Committee for Clinical Research of the Asturias Central
University Hospital and is in accordance with the 1975 Declaration of Helsinki, as
revised in 1983. Prior to the enrolment, all patients gave their written informed consent
to participate in the study.
Participants
The initial sample consisted of 186 patients who presented with SUD and received
treatment at any of the eight treatment centers participating in the study. Retention rate
at six months was 53.76 % (n = 100). Inclusion criteria were as follows: 1) age > 18 years;
2) primary diagnosis of SUD according to the ICD-10 diagnostic criteria; 3) patients
initiating or changing drug treatment because of lack of efficacy; and 4) written informed
consent.
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Eighty percent of patients were male, had a mean age of 40.49 years, and were never
married (40.3%). Almost half of the participants had less than elementary education
(48.9%) and 43.0% of the sample worked full time at baseline. About 7% had a physical
and 6% a psychological disability. Pattern of use was mainly alcohol abuse (54.3%),
followed by cocaine (19.9%), heroin (16.7%), and cannabis abuse (6.5%), although
results suggest that many substances are used simultaneously on a regular basis.
Moreover, each individual had received a mean of 3.3 (SD = 2.99) substance abuse
treatments. More than one-third of patients had ever been incarcerated, mostly for
property crimes (37%) or drug charges (11.1%), and 11.3% were presently awaiting
sentencing.
Instruments
–The ASI-6 is the latest version of the Addiction Severity Index tool (Cacciola,
Alterman, Habing and McLellan, in press; McLellan et al., 1980). The ASI is the
most widely used assessment tool in the addiction field. The sixth version
contains 257 items grouped into eight sections. The first two areas include
general information and the next six areas measure the severity of problems at
the time of the interview. The instrument assesses problem severity by calculating
recent summary scores (RSSs) ranging from 0 (no problem) to 1 (extreme severity)
in each of the domains.
– One hundred eighteen ASI-6 recent status items were subjected to nonparametric
item response theory (NIRT) analyses followed by confirmatory factor analysis
(CFA) (Cacciola et al., in press). One summary scale was derived from each of
six areas (medical, employment/economic, alcohol, drug, legal, and psychiatric)
and 3 RSSs were derived from the family/social area (family children, family/
social-support, and family/social problems); and finally, there were six secondary
scales relating to family, marital and social life, higher scores mean more severity
in the area. The degree of the internal consistency of the RSSs ranged between
.47 and .95; and for test-retest reliability, the values were acceptable, varying
from .36 to 1, being the average time between interviews 21.8 days (SD = 12.6;
Díaz-Mesa et al., 2010). These measures are expressed as T-scores with a mean
of 50 and a standard deviation of 10 based on the distribution of scores obtained
by Cacciola et al. (in press) with an urban substance abuse patient sample in
the United States.
– The Clinical Global Impression scale (CGI; Guy, 1976) is a descriptive scale that
provides a global rating of illness severity and improvement. The CGI-Severity
and CGI-Change scores are rated on a 7-point scale, higher scores mean worse
status. The Clinical Global Impression Scale is established as a core metric in
psychiatric research.
Procedure
The administration of the questionnaires was conducted in a personal interview in
the clinical setting by clinical staff. Patient characteristics were assessed at treatment
baseline using the Addiction Severity Index sixth version (ASI-6) and the Clinical Global
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Impression scale-Severity (CGI-S); initial assessment takes approximately one hour.
Evaluation of addiction severity at the six-month follow-up, in approximately 50 minutes,
included the ASI-6-FU (Addiction Severity Index Follow Up version) and the CGI
improvement/change scale (CGI-C and CGI-S).
Data analysis
First, the relationship between different variables and the addiction severity profile
were calculated using contingency tables, χ2 coefficient and the Pearson correlation (R),
as well as a Student’s t-test and analysis of variance in each case. Second, sensitivity
to therapeutic change was measured using a paired Student’s t-test and interclass
correlation coefficient (ICC) between baseline and six-month variables to determine the
stability of scores. Third, in order to determine which variables predicted adherence or
drop-out, a binary logistic regression analysis was carried out. Adherence to treatment
was entered as a dependent variable, while the predictors were demographic characteristics,
history of drug use, illegal activities, and RSSs of the ASI-6 at baseline. Several varia-
bles were coded as Dummy variables. Existence of interactions between key variables
was analyzed before submitting the final model. Statistical analysis was performed with
the Statistical Package for Social Sciences SPSS v.17.
Results
Changes in the addiction severity profile
As shown in Table 1, the most impaired primary area is the Alcohol Use; and the
family areas present also difficulties. We present means, standard deviations and ranges,
for understanding the different values of every scale. The correlations between the ASI-
6 and the CGI rated from .00 to .08 for the primary scales and from .31 to .62 for the
secondary scales.
TABLE 1. Addiction Severity Profile and psychosocial functioning (N = 186).
 
Severity measurements M (SD) Ranges 
CGI-S 4.35 (1.13) 0-8 
ASI-6 Primary scales 
Medical 44.42 (9.46) 29-78 
Employment 37.09 (12.85) 21-53 
Alcohol 53.57 (9.13) 38-77 
Drug 40.97 (11.09) 31-77 
Legal 47.08 (3.48) 46-79 
Family Child 49.82 (5.06) 48-79 
Family Social Support 45.10 (12.20) 27-73 
Family Social Problem 47.87 (9.08) 36-78 
Psychiatric 45.85 (8.94) 31-79 
ASI-6 Secondary Scales 
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Determining sensitivity of the ASI-6 to therapeutic change
Table 2 below reflects the mean addiction severity scores in the adherent patient
group as well as mean differences in the pre- and post-intervention measurements. Six
of the total primary scales met the criterion for change sensitivity by demonstrating a
decrease in severity after treatment. Nevertheless, only four of these nine scales fulfilled
a second criterion of significance (Alcohol, Drug, Psychiatric, and Family/Social Adult
Relatives Problems).
TABLE 2. Changes in Recent Summary Scores (RSSs) and Clinical Global
Impression at six months of treatment (N = 100).
TABLE 1. Addiction Severity Profile and psychosocial functioning (N = 186) (cont.).
 
Severity measurements M (SD) Ranges 
Family/Social Partner Support 43.10 (11.36) 32-57 
Family/Social Partner Problems 50.24 (7.29) 45-67 
Family/Social Friends Support 48.22 (9.46) 37-59 
Family/Social Friends Problems 48.89 (6.35) 46-70 
Family/Social Adult Relatives Support 48.98 (9.11) 41-68 
Family/Social Adult Relatives Problems 50.02 (7.48) 44-67 
ASI-6 Scales  Baseline 
M (SD) 
Follow-up 
M (SD) 
 
t 
 
p 
Medical 
 
 44.45 (9.15) 42.98 (8.20) 1.24 
.14 
Employment   38.53 (13.15) 38.36 (13.06) .145 .88 
Alcohol 
 
 54.35 (9.69) 49.48 (7.60) 4.80 
< .001 
Drug  38.42 (10.04) 36.60 (9.64) 2.14 .03 
Legal 
 
 46.69 (2.99) 46.04 (2.35) 1.65 
.10 
Problems with Children  50.00 (5.55) 54.35 (9.75) .00 1.00 
Family/Social Support   45.96 (11.97) 46.23 (12.02) -.244 .80 
Family/Social Problems   46.68 (8.49) 43.69 (6.72) 3.60 < .001 
Psychiatric 
 
 46.16 (8.73) 41.48 (8.54) 5.10 
< .001 
Clinical Global Impression 
CGI-C  4.46 (.97) 3.08 (1.34) 9.61 < .001 
Note: The number of subjects in the follow-up varies in each of the ASI-6 scale.
This positive progression is also found as assessed by the CGI-C, which means
some improvement in the dependency syndrome. Over six months, there was a statistically
significant decrease from a state of moderate-marked dependence (moderately ill, score
= 4.46) to slight dependence (mildly ill = 3.08). Family/Social Partner Problems RSS
was the secondary area with the best outcome (t = 2.61; p = .01). Regarding primary
scales, RSSs for Drug, Family Child, Psychiatric status, Employment, Family/ Social
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Support, and Family/Social Problems show strong temporal stability at six months of
follow-up (those with higher baseline scores also rated higher on follow-ups). Alcohol
and Medical RSSs show moderate and positive correlations, while Legal RSS does not
correlate with follow-up at six months (see Table 3). Secondary scales show high
positive correlations in Family/Social Partner Support and Family/Social Friends
Support scales. However, the rest of the secondary scales had positive but moderate
correlations.
TABLE 3. Intraclass Correlations Coefficients between baseline
Recent Summary Scores and six months follow-up RSSs and Pearson
Correlation (R) between RSSs and CGI-S.
 
  Pretest % Posttest % 
SA No SP 0 0 4 30.8 
 SP 5 38.5 6 46.2 
 Generalized 
SP 
8 61.5 3 23.1 
TA No SP 0 0 0 0 
 SP 4 50 6 75 
 Generalized 
SP 
4 50 2 25 
* p < .05, ** p < .01
Predictors of adherence/dropout
Adherence in the first six months was mainly related to age, severity and drug
abuse and baseline CGI-S. The CGI-S for those who stay in treatment is much higher
than those who drop out and the ASI-6 Drug scale is also significantly worse. The
Family/Social Support scale seems to play an important role (see Table 4).
TABLE 4. Significant Differences at baseline between adherent patients and Non-
adherent patients (length of stay > 6 months).
 
Variables Adherent patients 
(n = 100) 
Non-adherent 
patients 
(n = 86) 
t  -   Ȥ2 p 
Age (M, SD) 
 
42.81 (11.28) 37.81 (10.77) -3.07 .002 
CGI-S (M, SD) 4.05  (2.49) .93 (5.83) -4.85          .001 
Drug RSS (M, SD) 
 
39.00 (10.64) 43.31 (11.26) 2.40           .01 
Family/Social Adult Relatives 
Support RSS (M, SD) 
50.43 (9.53) 47.38 (8.37) -2.30          .02 
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The dependent variable is dichotomous and has two levels: (1) continue treatment
(or adherence) (code 1) and (0) drop out of treatment (no adherence) (code 2). We
decided to introduce into the regression equation variables that had been predictive in
the literature, specifically socio-demographic data (age, marital status –dummy variable–,
years of education, level of employment, current or past homelessness), primary derived
recent summary scales (representing severity in important areas of life of the person:
medical, psychological, social, family, work and legal), variables related to drug use (age
at onset of drug use, years of drug use, route of administration –dummy–) and criminal
variables (types of offenses –dummy–, age at first arrest). The reasons for the inclusion
of some of these variables is that these factors are influential on the course of the
patient’s life and habits of consumption that do not appear in the drugs / alcohol and
legal RSSs, as detailed below (see Table 5).
 
Variables Adherent patients 
(n = 100) 
Non-adherent 
patients 
(n = 86) 
t  -   Ȥ2 p 
TABLE 4. Significant Differences at baseline between adherent patients and Non-
adherent patients (length of stay > 6 months) (cont).
Marital status (F,%) 
  Married 
  Cohabiting 
  Widowed 
  Divorced 
  Separated 
  Never married 
 
29 (29.0) 
15 (15.0) 
1 (1.0) 
11 (11.0) 
0 (10.0) 
34 (34.0) 
 
27 (31.4) 
10 (11.6) 
3 (3.5) 
2 (2.3) 
3 (3.5) 
41(47.7) 
 
11.73         .03 
Main problem substance(F,%) 
  Alcohol 
  Marijuana 
  Sedatives 
  Cocaine 
  Heroin 
  Methadone 
  Other 
 
37 (43.0) 
10 (11.6) 
1 (1.2) 
25 (29.1) 
12 (14.0) 
1 (1.2) 
0 
 
64 (64.0) 
2 (2.0) 
0 
12 (12.0) 
19 (19.0) 
1 (1.0) 
2 (2.0) 
 
29.76       .004 
No Homelessness 47 (54.7) 71 (71.0) 7.61         .02 
Int J Clin Health Psychol, Vol. 11. Nº 3
CASARES-LÓPEZ et al. Sixth version of the Addiction Severity Index 503
TABLE 5. Items that form part of the calculation of the ASI-6 Primary Recent
Summary Scales: Drug and Alcohol RSSs.
Drug/ Alcohol 
Cumulative number of days of use for nine drugs/alcohol - past 30 days 
Cumulative number of days of use of six prescribed drugs - past 30 days 
Days of use of drugs or abuse of prescribed medication 
Days of at least 5 (men)/4 (women) drinks; When was the last drink? 
When last used drugs or abused prescribed medications? 
Money spent on drugs/alcohol? 
Withdrawal sickness 
Trouble controlling, cutting back, or quitting drugs/drinking 
Various problems because of drug use/drinking 
Days bothered by craving or urges to drink/use drugs 
Days with the above or any other difficulties 
Rating of trouble/bother by drug problems/alcohol problems 
Rating of importance of treatment for drug/alcohol use 
Legal 
Illegal income past 30 days  
Days sold or manufactured drugs in the past 30 days 
Days robbed anyone 
Days stolen anything, destroyed property, etc. 
Days done anything else illegal 
Days done anything illegal  
Next we conducted a logistic regression analysis. Criteria categories included in the
categorical independent variables are indicated, as well as the adjusted odds ratio (OR)
results and a 95% confidence index for each variable. The results of the binary logistic
regression analyses revealed that the only two factors significantly associated with lack
of adherence to outpatient treatment were the Clinical Global Impression- Severity and
the RSSs for Drug Use scale. This model explains 24% of the variance (Nagelkerke’s
R2= .239). The adjusted odds ratio related to an increased probability of adherence was
1.23 for higher CGI-S score (95% CI 1.10-1.38). On the contrary, higher risk of drop out
was predicted by higher score in the Drug RSS with an OR of .95 (95% CI .92-.98). In
summary, older age, less drug severity, more family social support, and higher CGI
severity were associated with adherence.
Discussion
The main goal of this study was to check the adequate psychometric performance,
in terms of convergent-discriminant validity and sensitivity to change. The convergent-
discriminant validity evidence in this study, the correlations between the primary and
secondary scales of the ASI-6 and the Clinic Global Impression score were low, with
values from .01 to .26. In our study, the correlations were from .00 to .08 and from .31
to .62 (primary and secondary ASI -6, respectively).
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Díaz-Mesa et al. (2010) found low correlation between the scales of the ASI-6 and
the score on the ICG-G. We should note that the ICG is a subjective assessment tool,
and the clinician takes into account a number of parameters not previously defined,
focusing mainly on aspects of physical and mental health. This has influence on the
low validity and underlines the importance of using instruments that previously defined
the dimensions for adequately assess the severity of addiction. Regarding the discriminant
validity, it appears that the instrument is a good tool for grading the following primary
scales: Employment, Drug and Alcohol, Family Social Support, Family and Social
Problems, and Psychiatric area.
At the six-month follow-up, the Spanish version of the ASI-6 found the existence
of statistically significant changes in many domains related to the patient’s life compared
to the baseline assessment. The primary areas show a statistically significant reduction
in severity at six months of treatment (Alcohol, Drug, Mental Health, and Family/
Social Partner problems), and in all areas evaluated patients improved after treatment.
For secondary areas, treatment effect was particularly positive in the domain of Family/
Social Partner Problems. Paradoxically, although more than 80% of the sample were
men, the severity of problems with children increased on follow-up scores. This suggests
that patients who spend more time at home as part of a stimulus control intervention,
and therefore they can realize in the difficulties in dealing with their own children. These
problems could have existed previously, masked by the use of drugs. It is important to
note that client-perceived social and family support explained a significant proportion
of the variance in treatment adherence, in keeping with other studies (Soyez, De Leon,
Broekaert, and Rosseel, 2006).
Data show that there was a substantial decline in substance use (both alcohol and
other drugs) during treatment as reflected in the Alcohol and Drug RSSs. This is logic,
both, drug and alcohol severity, decreased in the time period of six months, but the
relatively low temporal stability for alcohol, reflects the fact that the majority of patients
were alcohol abusers and the treatment did have effect on alcohol severity. Other
studies (Chutuape, Jasinski, Fingerhood, and Stitzer, 2001) have noticed therapeutic
changes in the same direction, such as a 50% reduction in heroin from pre- to post-
detoxification; these findings are repeated with cocaine and alcohol. Investigating short-
term outcomes of a three-day medical detox, 166 heroin abusers completed the Addiction
Severity Index during detoxification, and at 1, 3, and 6 months after detoxification. These
outcomes demonstrate that brief inpatient detoxification is followed by reduced drug
use over several months and is accompanied by substantial treatment-seeking behavior.
Across the post-detoxification interviews, mean days of reported heroin use ranged
from 11 to 14; 21–30% of patients reported no heroin use, whereas 25–36% reported
almost daily use. Reported use of cocaine and alcohol showed similar reductions from
pre- to post-detoxification (verified through urine tests).
Other authors (Hubbard, Craddock, and Anderson, 2003) describe the long-term
outcomes of drug treatment in terms of cocaine use and other areas of the individual’s
life, such as employment status and legal situation. The 5-year follow-up of 1393
subjects shows a significant reduction in cocaine use compared with the pre-treatment
year, associated mainly with long-term treatment (in particular, six months or more in
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long-term residential program and outpatient drug-free program). Furthermore, reductions
in illegal activity and increases in full-time employment were associated with treatment
stays of six months or longer in long-term residential programs. In our study, we found
improvements at six months in substance use and a small decrease in the severity of
employment situation, but no change in the legal domain. The nonexistence of changes
in the legal area may be due to the prevalence of alcohol-dependent patients in the
sample. Alcohol use is more integrated into Spanish society, and people are not stigmatized
or marginalized for it. Another explanation is that individuals with antisocial personalities
and criminal behavior receive inpatient treatment with greater control and therefore are
not represented in this outpatient treatment.
Improvement in mental health is demonstrated by a moderate decrease of five
points in psychopathology area scores. This is also consistent with other studies
(Gossop, Marsden, and Stewart, 2006), in which 662 drug-dependent adults treated with
methadone experienced a reduction in their psychiatric symptom scores at one-month
and six-month follow-up. Of importance is the fact that mitigation of psychopathology
is positively related to treatment adherence. High dropout rates from treatment programs
is one of the most serious problems in the field of drug addiction, with an average rate
of early attrition of 55% (Gainey, Wells, Hawkins, and Catalano, 2003). Often, the
consequences of dropping out are negative impact on areas of the subject’s life and
relapse into drug abuse. Moreover, this has been pointed out as a key factor limiting
the effectiveness of treatment (Carroll, 1997; Onken, Blaine, and Boren, 1997).
Moderate evidence has been collected to describe predictors of client adherence.
Sayre et al. (2002) conducted an evaluation of 165 individuals seeking treatment for
cocaine dependence. Treatment dropouts were more likely to be divorced, have fewer
years of education, have poorer family/social functioning, and to be female. However,
those participants with higher education levels and those with poorer psychiatric
functioning tended to stay in treatment longer. Though we have considered these
variables in our study, the only coincident factor is marital status. Some studies have
shown that demographic variables are not strong predictors of retention (Carroll,
Rounsaville, and Gawin, 1991; Gainey et al., 1993), but it is also true that others have
found the opposite (Agosti, Nunes, Stewart, and Quitkin, 1991; Kleinman et al., 1992).
Although some studies found that males are more likely than females to drop out
of treatment (Onken et al, 1997), other studies have found the contrary (Carroll, 1997;
Sayre et al., 2002); and many other studies have failed to find gender to be a significant
predictor of treatment outcome (Carroll et al., 1991; Gossop et al., 2006; Onken et al.,
1997). Race has also been one of the hypotheses (McCaul, Svikis, and Moore, 2001;
Mertens and Weisner, 2000), but there are no conclusive data, in any case, all the
patients interviewed were Caucasian. Some authors (Onken et al., 1997) have identified
lower attrition rates in ethnic minorities with higher education, and others (Manu,
Burleson, and Kranzler, 1994; Means et al., 1989) regardless of race or ethnicity, dropped
out prematurely but this was better explained by lower educational level. In our study,
none of the socio-demographic variables has demonstrated a predictive power with
regard to treatment adherence. It is true that people who have lived in poverty in the
past are more likely to remain in treatment, and this may be related to family support
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and marital status, which may play an important role in establishing healthy functional
relationships, along with employment (Means et al., 1989; McCaul et al., 2001; Mertens
and Weisner, 2000). Data from previous studies already showed that in adolescence,
more time spent in leisure activities were related to greater involvement in substance
use, and there is a protection effect of family and school self-esteem on substance use
(Ciairano, Bosma, Miceli, and Settanni, 2008; Jiménez, Musitu, and Murgui, 2008).
Drug and alcohol use at the time of seeking treatment as well as the severity of
drug use have also been hypothesized as predictive variables. Patients with drug use
disorder were presumed to have poorer treatment participation and worse retention than
those patients with an alcohol use disorder. But subsequent studies have found no
consistent results (McCaul et al., 2001; Mertens and Weisner, 2000). Interestingly,
several reports indicate that cocaine use at baseline is an important predictor of outcomes
for inpatient and outpatient treatment programs (Alterman, McKay, Mulvaney, and
McLellan, 1996; Alterman et al., 1997; Rhoades, Creson, Elk, Schmitz, and Grabowski,
1998). These results suggest that inability to establish abstinence before treatment is
more likely to occur among those with more severe addiction. Data from our study
suggest that those using opiates and heroin longer and using methadone for fewer
years are more likely to remain in treatment. Other researchers have examined predictors
of participation and retention in a hospital-based outpatient treatment setting (McCaul
et al., 2001). They assessed the severity of addiction of 268 patients with the ASI at
baseline and found that the status of substance use did not predict treatment participation
or retention, whereas race, gender, and employment composite scores were significant
predictors.
Limitations of this study include external validity of results as data are limited to
public health system patients. Also, female or young users may not have been well
represented in the sample; this also applies to individuals with a worse severity profile
in the legal area, as many such people are incarcerated. The impossibility of having a
random group and the composition of the sample by patients initiating or changing drug
treatment may be a methodological limitation, but it reflects the everyday clinical reality.
However, this study has important implications for future development of substance
abuse treatment services and yields a trend to elucidate and examine potential variables
that will improve our accuracy in recruiting subjects, achieve higher rates of adherence,
and personalize each type of treatment for each individual needs.
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